Benson Smith Sells 9,331 Shares of Teleflex Incorporated (NYSE:TFX) Stock

Share on StockTwits

Teleflex Incorporated (NYSE:TFX) Director Benson Smith sold 9,331 shares of the business’s stock in a transaction that occurred on Monday, September 17th. The stock was sold at an average price of $266.73, for a total transaction of $2,488,857.63. Following the completion of the transaction, the director now directly owns 77,887 shares of the company’s stock, valued at approximately $20,774,799.51. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Benson Smith also recently made the following trade(s):

  • On Monday, October 8th, Benson Smith sold 9,331 shares of Teleflex stock. The stock was sold at an average price of $250.31, for a total transaction of $2,335,642.61.
  • On Monday, August 27th, Benson Smith sold 9,331 shares of Teleflex stock. The stock was sold at an average price of $247.69, for a total transaction of $2,311,195.39.
  • On Monday, August 6th, Benson Smith sold 9,331 shares of Teleflex stock. The stock was sold at an average price of $241.84, for a total transaction of $2,256,609.04.
  • On Monday, July 16th, Benson Smith sold 9,331 shares of Teleflex stock. The stock was sold at an average price of $272.07, for a total transaction of $2,538,685.17.
  • On Monday, June 25th, Benson Smith sold 9,331 shares of Teleflex stock. The stock was sold at an average price of $275.32, for a total transaction of $2,569,010.92.

Shares of Teleflex stock traded up $3.70 during trading on Friday, reaching $248.25. The company’s stock had a trading volume of 317,211 shares, compared to its average volume of 305,596. Teleflex Incorporated has a 52-week low of $227.52 and a 52-week high of $288.78. The stock has a market capitalization of $12.19 billion, a price-to-earnings ratio of 29.55, a price-to-earnings-growth ratio of 1.87 and a beta of 1.12. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.45 and a current ratio of 2.21.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 2nd. The medical technology company reported $2.47 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.41 by $0.06. Teleflex had a net margin of 3.78% and a return on equity of 17.32%. The company had revenue of $609.87 million during the quarter, compared to analysts’ expectations of $615.97 million. During the same quarter in the prior year, the company earned $2.04 EPS. The firm’s revenue was up 15.4% on a year-over-year basis. On average, equities research analysts forecast that Teleflex Incorporated will post 9.82 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 14th. Stockholders of record on Wednesday, August 15th were paid a $0.34 dividend. The ex-dividend date was Tuesday, August 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.55%. Teleflex’s dividend payout ratio (DPR) is 16.19%.

A number of equities analysts have commented on TFX shares. Needham & Company LLC cut their price target on shares of Teleflex from $298.00 to $279.00 and set a “buy” rating for the company in a research note on Friday, August 3rd. Morgan Stanley cut their price objective on shares of Teleflex from $310.00 to $295.00 and set an “overweight” rating for the company in a research note on Friday, August 3rd. ValuEngine cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, August 3rd. Finally, TheStreet cut shares of Teleflex from a “b” rating to a “c+” rating in a research note on Friday, August 3rd. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $289.25.

A number of institutional investors and hedge funds have recently made changes to their positions in TFX. Robeco Institutional Asset Management B.V. boosted its position in Teleflex by 49.0% during the 1st quarter. Robeco Institutional Asset Management B.V. now owns 2,229 shares of the medical technology company’s stock valued at $568,000 after buying an additional 733 shares during the period. Schwab Charles Investment Management Inc. boosted its position in Teleflex by 4.4% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 188,133 shares of the medical technology company’s stock valued at $47,971,000 after buying an additional 7,961 shares during the period. Aperio Group LLC boosted its position in Teleflex by 7.3% during the 1st quarter. Aperio Group LLC now owns 14,552 shares of the medical technology company’s stock valued at $3,710,000 after buying an additional 986 shares during the period. Neuberger Berman Group LLC boosted its position in Teleflex by 14.7% during the 1st quarter. Neuberger Berman Group LLC now owns 6,611 shares of the medical technology company’s stock valued at $1,686,000 after buying an additional 848 shares during the period. Finally, Korea Investment CORP boosted its position in Teleflex by 11.2% during the 1st quarter. Korea Investment CORP now owns 22,806 shares of the medical technology company’s stock valued at $5,815,000 after buying an additional 2,306 shares during the period. 88.89% of the stock is owned by institutional investors and hedge funds.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Recommended Story: Trading Strategy

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply